ストックスクリーナーアプリを入手
887.29
1.36%
-12.27
アフターアワーズ：
887.29
Mckesson Corp (MCK) 最新ニュース
Lawsuits Over McKesson Voice-Phishing Attack Points to Ongoing Risk in Healthcare Sector - Law.com
McKesson stock heads into the open after a 1.2% drop - ad-hoc-news.de
McKesson (MCK) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
McKesson Corp. stock underperforms Thursday when compared to competitors - MarketWatch
McKesson Corp (MCK) Insider Sale: SVP, Controller & CAO Rutledge Napoleon B JR Sells 111 Shares - GuruFocus
McKesson (MCK) Plans A $2.25b Deal, Is The Stock Fully Valued? - simplywall.st
McKesson Senior VP Napoleon Rutledge Jr. Sells 111 Shares via 10b5-1 Trading Plan - Kalkine Media
ShinyHunters expose 6.4M in attack on medical supplier McKesson - The Register
McKesson stock heads into the open after a 1.5 percent slide - ad-hoc-news.de
Why Is McKesson (NYSE:MCK) Stock In Focus Today? - Kalkine Media
McKesson (NYSE:MCK): Is the Cyber Risk Overpriced? - Kalkine Media
McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
McKesson Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
McKesson Eyes $2.25B Precision Medicine Deal as Oncology Growth Accelerates - Yahoo Finance
McKesson at wells fargo healthcare conference: growth, deal push - investing.com
McKesson Corp's negligence caused a data breach, a new class action lawsuit claims - claimdepot.com
Novocure Reports Patient Data Exposure in Cybersecurity Incident - Zacks Investment Research
McKesson Bets $2.25 Billion More on Oncology With Precision Medicine Buy - Yahoo Finance
McKesson Stock (MCK) Opinions on Recent Data Leak and Market Dynamics - Quiver Quantitative
Mckesson Stock Price Forecast. Should You Buy MCK? - StockInvest.us
McKesson Owns Antitrust Claims, Not Rite Aid, Judge Finds - Law360
McKesson Corp. stock underperforms Friday when compared to competitors - MarketWatch
McKesson Corp (MCK) Stock Price, Quote, News & History - Benzinga
McKesson Data Breach: Investigation Ongoing - Claim Depot
Why Is McKesson (MCK) Up 5.7% Since Last Earnings Report? - finance.yahoo.com
McKesson Stock: Is MCK Outperforming the Healthcare Sector? - Barchart.com
Mckesson Corporation (MCK) News, Articles, Events & Latest Updates - Stocktwits
McKesson Corp. stock outperforms competitors on strong trading day - MarketWatch
McKesson confirms data theft in cyberattack involving third-party apps - finance.yahoo.com
Mckesson Corp Stock (MCK) Moved Up by 3.13% on Sep 1: Key Drivers Unveiled - tradingkey.com
McKesson data breach exposes prescribing physicians and their patients to fallout from a third-party attack - Medical Economics
Here's How Much a $1000 Investment in McKesson Made 10 Years Ago Would Be Worth Today - Yahoo Finance
ShinyHunters Threatens to Leak Millions of McKesson Records - BankInfoSecurity
McKesson Hit by Cyberattack Affecting 284M Patient Records - Medical Device and Diagnostic industry
McKesson Okta and Cloud Services Breach Analysis: ShinyHunters Vishing Attack Leads to Major Healthcare Data Exfiltration - Rescana
McKesson Corporation: Ademi LLP Investigates Claims for Damages - GlobeNewswire
Mckesson CorpDiscovers Cybersecurity Incident Affecting Information Systems On August 25, 2026SEC Filing - TradingView
8 things to know: Drug distribution giant to buy Maryland firm for $2.25B - The Business Journals
McKesson Corporation (MCK) Doubles Down on Healthcare Growth With Precision Medicine Acquisition - Yahoo Finance
Amid layoffs including at Rx Savings in OP, parent McKesson plans $2.25B acquisition - The Business Journals
What Does McKesson (MCK) Gain From Its Push Into Oncology And Clinical Research? - Yahoo Finance
McKesson to acquire Precision Medicine Group for $2.25bn - finance.yahoo.com
McKesson Corp (MCK) Stock Up 3.6% but GF Value Says Overvalued -- GF Score: 87/100 - GuruFocus
McKesson Snags Precision Medicine Group In $2.25B Deal - Law360
Here's Why You Should Retain McKesson Stock in Your Portfolio for Now - TradingView
McKesson to acquire Precision Medicine Group - Chain Drug Review
Is McKesson Stock Worth Buying as Growth Meets a Premium Valuation? - Eastern Progress
Mckesson Corp Stock (MCK) Moved Up by 3.13% on Aug 21: A Full Analysis - TradingKey
McKesson gains as investors lean on strong earnings backdrop and recent guidance lift - Quiver Quantitative
McKesson (MCK) Stock May Trade At A Discount As Cash Flow Holds Up - Yahoo Finance
McKesson Corp. stock outperforms competitors despite losses on the day - MarketWatch
LLY4104766 Bond Profile — Key Metrics - TradingView
McKesson Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
MCKESSON CORP : RBC INITIATES COVERAGE WITH SECTOR PERFORM RATING; TARGET PRICE $845 - Bitget
Winners And Losers Of Q2: McKesson (NYSE:MCK) Vs The Rest Of The Healthcare Providers & Services Stocks - Yahoo Finance
McKesson Corp. stock underperforms Monday when compared to competitors - MarketWatch
McKesson director Bradley Lerman sells $268,589 in shares By Investing.com - Investing.com Australia
McKesson director Bradley Lerman sells $268,589 in shares - Investing.com
Summit Global Investments Invests $1.16 Million in McKesson Corporation $MCK - MarketBeat
1.48%
大文字化:
|
ボリューム (24 時間):